FDA Newsfeed

StockMarketWire.com - Cancer and inflammatory diseases focused Tiziana Life Sciences said the US Food and Drug Administration had allowed the initiation of a clinical trial of a treatment for autoimmune and inflammatory diseases. The Phase I clinical trial …

… spreadsheet outlining their corrections, however, FDA evaluation of the response revealed … to control scombrotoxin (histamine) formation. “FDA recommends a critical limit that … of incoming scombroid species fish, FDA recommends conducting a sensory examination …

… . Food and Drug Administration (FDA) would soon issue guidance on … take months to achieve. The FDA called teen vaping an “ … tobacco products. This means the FDA could stop e-cigarette manufacturers … the Trump Administration said the FDA intends to finalize a new …

… that could cause cancer. FDA said some ranitidine products commonly … could cause cancer. The FDA has been investigating NDMA and … since last year. "The FDA is not calling for individuals … other treatment options," the FDA said in the statement. …

… the drugs that cleared the FDA hurdle this week include Ardelyx … , in Dallas PDUFA Dates The FDA is set to rule on … Semaglutide is pending before the FDA. The PDUFA action date for …

… ;re investigating, as well. The FDA had been alerted by Valisure … it sells, has asked the FDA to recall Zantac and the … the levels excessive, which the FDA disagrees with. "We don … to human health," an FDA spokesperson said, "so we …

… Food and Drug Administration. An FDA advisory panel voted Friday to …

… warning sent to Juul, acting FDA Commissioner Ned Sharpless said claiming … an uphill battle. While the FDA has long been suspicious of … e-cig approved by the FDA when it submits its … would appear immaterial if the FDA determines Juul Labs violated regulations …

News The Food and Drug Administration is one step closer to approving a potentially life-saving peanut allergy treatment.  Saturday, September 14th 2019, 2:11 PM EDT Updated: Saturday, September 14th 2019, 2:54 PM EDT

“I voted ‘yes’ because I thought the data was quite clear, and I would actually compliment the sponsor on the extent and caliber of the studies,” Ira Finegold, a professor of medicine at Icahn School of Medicine at Mount Sinai in New York, told NPR.

… S. Food and Drug Administration (FDA) has learned that some acid … S. Food and Drug Administration (FDA) has issued warning about a … of NDMA. Therefore, while the FDA “is not calling for individuals … past year, this latest FDA announcement does seem like déjà …

… an implicit admission that the FDA’s efforts to date … fruit- or mint-flavored. The FDA might have given its previous … would have to convince the FDA that their products protect public … health. This means FDA regulators must still consider whether …

… the contamination occurred. However, the FDA said the chemical “is a … , are not included in the FDA’s notice. The agency said … China, were dangerously high. The FDA is continuing to investigate the …

… working with the FDA." The FDA said NDMA is … Agency officials said the FDA is investigating whether low … officials deemed acceptable. The FDA is still investigating that issue … globally. For decades the FDA focused its manufacturing inspections on …

… leader in radiotherapy, has received FDA 510(k) clearance for the …

… an endorsement for approval. The FDA is expected to make its …

"It was mostly because I myself didn't even know it was an issue. I was scrolling through different countries policies towards the LGBTQ community and I saw the blood donor controversy and I was like 'oh, this is not good',” said Houck.

… the brand-name drug Zantac FDA said NDMA is classified as … failure medicines since last year. FDA has recommended numerous recalls of … drugs as a result. The FDA said it's still … who take them. So far, FDA said the the levels it …

… of independent advisors to the FDA voted on Friday to … s precedent for drugs winning FDA approval based on surrogate … yes” vote, Marshall said the FDA can monitor Palforzia over time … has also sparked safety concerns. FDA scientists noted that the treatment …

… ’ eyes were trained on an FDA Advisory Committee hearing Friday. The … , Aimmune, filed paperwork with the FDA seeking approval for children 4 …

… medication. According to the FDA on Friday, small amounts … were also launched after the FDA found “unacceptable levels” of … ranitidine at this time,” FDA spokesman Jeremy Kahn said via … Janet Woodcock, research director for FDA’s Centers for Drug Evaluation …

… favor of the treatment, the FDA will make its final approval … , this will become the first FDA approved treatment for peanut allergy …

… Zantac. Despite the warnings, the FDA said it was not calling … large amounts, the levels the FDA is finding in ranitidine from … has been labeled by the FDA as a cancer-causing substance …